openPR Logo
Press release

Global Cushing's Syndrome Treatment Market: Supply Chain, Revenue, and Regional Analysis till 2029

02-19-2021 12:48 PM CET | Health & Medicine

Press release from: PROPHECY MARKET INSIGHTS

Prophecy Market Insights

Prophecy Market Insights

The Global Cushing’s Syndrome Treatment Market accounted for US$ 313.0 million in 2020 and is estimated to be US$ 676.2 million by 2029 and is anticipated to register a CAGR of 8.9%%. Cushing's syndrome is a hormonal disorder caused by high levels of the hormone cortisol in the body. It’s also known as hypercortisolism. Cortisol is produced in adrenal glands, which are on top of your kidneys. It helps the body:

Maintain blood pressure
Regulate blood sugar
Lower inflammation
But when you have too much cortisol, it can throw off your body's other systems. Most cases of Cushing's syndrome can be cured, though it may take some time for the symptoms to ease up. The condition is more common in women than in men. It's most often seen in people aged 25-40.

The report "Global Cushing’s Syndrome Treatment Market,) By Treatment(surgery, Radiation Therapy, Medication), By Drug type (Ketoconazole, Etomidate, Pasireotide, and Aminoglutethimide), By End-user (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Clinics, e-Commerce/Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

Request Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3009

Key Highlights:

According to the National Center for Biotechnology Information, to normalize the devastating disease effects of hypercortisolemia, it is paramount that successful patient disease management includes individualized, multidisciplinary care, with close collaboration between endocrinologists, neurosurgeons, radiation oncologists, and general surgeons. This commentary will focus on recent advances in the medical treatment of Cushing's, with a focus on newly approved ACTH modulators and glucocorticoid receptor blocker.
According to U.S. food and drug administration on 6th march 2020, The U.S. Food and Drug Administration approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either cannot undergo pituitary gland surgery or have undergone the surgery but still have the disease. Cushing’s disease is a rare disease in which the adrenal glands make too much of the cortisol hormone. Isturisa is the first FDA-approved drug to directly address this cortisol overproduction by blocking the enzyme known as 11-beta-hydroxylase and preventing cortisol synthesis
According to American association of Neurological surgeon, Cushing’s syndrome (also known as Pituitary Adenomas) account for more than 70% in adults and about 60-70% in children and adolescents. Cushing’s syndrome commonly affects adults aged between 20-50 and is more prevalent in females, accounting for about 70% of all cases.

To overcome this syndrome many key players are coming up with new advancements. For instance, in November 2019, Osilodrostat, which is used for the treatment of patient with Cushing syndrome in adults, received positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). Furthermore, on 6th March 2020, Isturisa (osilodrostat) was approved by the U.S Food and Drug Administration (FDA). Isturisa (osilodrostat) is an oral tablet used in the patients who cannot go for pituitary gland surgery or has not been curative.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Cushing's Syndrome Treatment Market,) By Treatment(surgery, Radiation Therapy, Medication), By Drug type (Ketoconazole, Etomidate, Pasireotide, and Aminoglutethimide), By End-user (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Clinics, e-Com)”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Cushings-Syndrome-Treatment-Market-3009

Key Market Insights from the report:

The Global Cushing’s Syndrome Treatment Market accounted for US$ 313.0 million in 2020 and is estimated to be US$ 676.2 million by 2029 and is anticipated to register a CAGR of 8.9%. The Global Cushing’s Syndrome Treatment Market is segmented based on the application, treatment, drug type, market and region.

By treatment, the market is segmented in surgery, Radiation Therapy, Medication.
By drug type, the Global Cushing’s Syndrome Treatment Market is segmented into Ketoconazole, Etomidate, Pasireotide, and Aminoglutethimide.
By end-user, the Global Cushing’s Syndrome Treatment Market is segmented into (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Clinics, e-Commerce/Online Pharmacies)
By region, the Global Cushing’s Syndrome Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the worldwide leader in the Cushing’s syndrome treatment market in terms of revenue, due to the developed healthcare system and health awareness among people.
Competitive Landscape:

The key players operating in the global Cushing’s syndrome treatment market include Pfizer, Corcept Therapeutics Inc., Novartis, Strong Bridge Biopharma, Orphagen Pharmaceuticals, Inc., and HRA Pharma.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered

Introduction
Study Deliverables
Study Assumptions
Scope of the Study
Research Methodology
Executive Summary
Opportunity Map Analysis
Market at Glance
Market Share (%) and BPS Analysis, by Region
Competitive Landscape
Heat Map Analysis
Market Presence and Specificity Analysis
Investment Analysis
Competitive Analysis

Contact Us:

Sales
Prophecy Market Insights
860 531 2701
Email- sales@prophecymarketinsights.com

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cushing's Syndrome Treatment Market: Supply Chain, Revenue, and Regional Analysis till 2029 here

News-ID: 2245563 • Views:

More Releases from PROPHECY MARKET INSIGHTS

Floating Power Plant Market: Powering the Future of Renewable Energy
Floating Power Plant Market: Powering the Future of Renewable Energy
Introduction The Floating Power Plant Market is rapidly emerging as a transformative solution to the world's growing energy needs. With increasing global demand for sustainable, flexible, and decentralized power generation, floating power plants (FPPs) are gaining traction as they can be deployed in offshore waters, lakes, and reservoirs. These plants integrate renewable energy sources like wind, solar, and wave energy with conventional power systems, providing a reliable energy mix. Driven by rising
AI-Enabled Kitchen Appliances Market: Driving the Future of Smart Living
AI-Enabled Kitchen Appliances Market: Driving the Future of Smart Living
Introduction The AI-Enabled Kitchen Appliances Market is experiencing unprecedented growth as artificial intelligence becomes a core component of modern homes. With the rise of smart homes, connected devices, and consumer demand for convenience, AI-driven appliances are redefining the way people cook, store, and manage food. From refrigerators that track expiry dates to ovens that auto-adjust based on recipes, these innovations are revolutionizing kitchens worldwide. Industry forecasts suggest that the market will witness
Europe Dominates 2024 Residential Energy Storage Market, Poised for 9.5% CAGR Growth
Europe Dominates 2024 Residential Energy Storage Market, Poised for 9.5% CAGR Gr …
The Residential Energy Storage Market is witnessing strong momentum, expected to grow from USD 2.8 billion in 2024 to USD 6.8 billion by 2035, expanding at a robust CAGR of 9.5% (2025-2030). Europe led the global market in 2024 owing to its significant investments in renewable energy integration, supportive government policies, and growing demand for energy independence. Unlock the full potential of the Residential Energy Storage Market with in-depth insights, market
Commercial Refrigeration Equipment - A Cornerstone for Food Quality and Sustainability, Market to Reach USD 71.8 Billion by 2035
Commercial Refrigeration Equipment - A Cornerstone for Food Quality and Sustaina …
The Commercial Refrigeration Equipment Market is set for significant expansion, growing from USD 43.0 billion in 2024 to USD 71.8 billion by 2035, progressing at a CAGR of 5.3% (2025-2035). The Asia Pacific region held the largest share in 2024 and continues to dominate due to rising demand for advanced refrigeration solutions across retail, foodservice, and cold-chain logistics. Gain in-depth insights into the Commercial Refrigeration Equipment Market, including regional forecasts, emerging

All 5 Releases


More Releases for Cushing

Cushing Syndrome Market Trends is Electrifying Growth Cycle: Bristol Myers Squib …
The latest study released on the Global Cushing Syndrome Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players
Cushing Syndrome Pipeline Appears Robust With 4+ Key Pharma Companies Actively W …
DelveInsight's, "Cushing Syndrome Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cushing Syndrome pipeline landscape. It covers the Cushing Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cushing Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Cushing Syndrome
Cushing Syndrome Market Is Booming So Rapidly | Recordati, Diurnal Group, Pfizer
The Global Cushing Syndrome Market Size is estimated at $1.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 22.6% to reach $8.8 Billion by 2034. The latest study released on the Global Cushing Syndrome Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Cushing Syndrome market study covers significant research data and proofs to be a handy resource document for
The Cushing’s Disease Treatment Market to grow at an invigorating pace in the …
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease
Somatostatin Analogs Market Report 2018: Segmentation by Product (Octreotide, La …
Global Somatostatin Analogs market research report provides company profile for Chiasma, Ipsen Biopharmaceutical, Novartis, Peptron and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the basis of
Cushing’s Disease Treatment Market Forecast over 2017 – 2025
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease